[
    [
        {
            "time": "2023-10-18",
            "original_text": "5.32亿欧元 迈瑞医疗完成对免疫原材料供应商并购交易",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "并购",
                    "免疫原材料",
                    "HyTest"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "5.32亿欧元 迈瑞医疗完成对免疫原材料供应商并购交易",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "嗅到牛市味道？这家海外巨头连续3月大笔买入券商股",
            "features": {
                "keywords": [
                    "海外巨头",
                    "券商股",
                    "买入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "嗅到牛市味道？这家海外巨头连续3月大笔买入券商股",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "迈瑞医疗完成并购全球领先免疫原材料供应商HyTest",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "并购",
                    "HyTest",
                    "免疫原材料"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "迈瑞医疗完成并购全球领先免疫原材料供应商HyTest",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "[中国好公司]迈瑞医疗：差异化策略成功抢占市场份额 被集采“错杀”的大白马？",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "差异化策略",
                    "市场份额",
                    "集采",
                    "错杀"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[中国好公司]迈瑞医疗：差异化策略成功抢占市场份额 被集采“错杀”的大白马？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "迈瑞医疗完成收购海肽生物 IVD产品自主研发能力将获突破",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "收购",
                    "海肽生物",
                    "IVD",
                    "自主研发"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "迈瑞医疗完成收购海肽生物 IVD产品自主研发能力将获突破",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "迈瑞医疗并购全球领先免疫原材料供应商HyTest交易完成 深化产业链布局",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "并购",
                    "HyTest",
                    "免疫原材料",
                    "产业链布局"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "迈瑞医疗并购全球领先免疫原材料供应商HyTest交易完成 深化产业链布局",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "迈瑞医疗完成收购HyTest 助力国内IVD行业供应链稳定",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "收购",
                    "HyTest",
                    "IVD",
                    "供应链稳定"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "迈瑞医疗完成收购HyTest 助力国内IVD行业供应链稳定",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "迈瑞医疗完成对免疫原材料供应商海肽生物的并购交易，交易价款5.32亿欧元",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "并购",
                    "海肽生物",
                    "免疫原材料"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "迈瑞医疗完成对免疫原材料供应商海肽生物的并购交易，交易价款5.32亿欧元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]